SCHEMBL14563296

SCHEMBL14563296

O=C1c2ccccc2C(=O)N1C[C@@H]1CCCN1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
MAP3K7 O43318 1/20 0.49
TAB1 Q15750 1/20 0.49
PARP1 P09874 1/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
HTR1A P08908 2/20 0.43
HTR1D P28221 2/20 0.43
HTR2A P28223 2/20 0.43
HRH1 P35367 2/20 0.43
ADRA1B P35368 2/20 0.43
KCNH2 Q12809 2/20 0.43
POLB P06746 1/20 0.42
ACHE P22303 1/20 0.41
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CACNA2D1 P54289 1/20 0.40
CACNA1B Q00975 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15672061 1.00 CYP1A2 (0.51) CYP1A2CYP2C9CYP2C19MAP3K7TAB1
Hydrochloric Acid SCHEMBL5426189 0.98 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19MAP3K7TAB1
SCHEMBL14921361 0.95 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19MAP3K7TAB1
SCHEMBL21564438 0.79 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19KEAP1HTR2A
SCHEMBL17009264 0.79 CYP2C9 (0.47) CYP1A2CYP2C9CYP2C19KEAP1NFE2L2
SCHEMBL16277451 0.79 CYP2C9 (0.47) CYP1A2CYP2C9CYP2C19KEAP1NFE2L2
SCHEMBL16277278 0.79 CYP2C9 (0.47) CYP1A2CYP2C9CYP2C19KEAP1NFE2L2
Hydrochloric Acid SCHEMBL27677247 0.79 ACHE (0.50) CYP1A2CYP2C9CYP2C19HTR1AHTR1D
SCHEMBL29946845 0.78 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19KEAP1HTR2A
Hydrochloric Acid SCHEMBL6789716 0.78 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19KEAP1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014069626-A1 METHOD FOR PRODUCING PYRIMIDODIAZEPINONE COMPOUND 協和発酵キリン株式会社 (JP) 2014-05-08 WO disclosed
US-20070065898-A1 Fluorescence polarization assays for binding of caspase inhibitors and probes therefor WYETH (US) 2007-03-22 US disclosed
US-20070065898-A1 Fluorescence polarization assays for binding of caspase inhibitors and probes therefor WYETH (US) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070065898-A1 Fluorescence polarization assays for binding of caspase inhibitors and probes therefor APAF1, CASP1, CASP14 CYP1A2 3626/4885CYP2C9 3913/4885CYP2C19 3044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.